Literature DB >> 8147273

Ropivacaine and lidocaine inhibit proliferation of non-transformed cultured adult human fibroblasts, endothelial cells and keratinocytes.

T Martinsson1, A Haegerstrand, C J Dalsgaard.   

Abstract

Local anaesthetics are known to affect a variety of cell functions, many of which are involved in the inflammatory response. Local anaesthetics have also been shown to influence cell proliferation. The aim of this study was to examine the effect of two local anaesthetics (ropivacaine and lidocaine) on cell proliferation of cultured human fibroblasts, vascular endothelial cells and epithelial cells, i.e. keratinocytes, as earlier studies have not included primary human cell types. Significant inhibition of fibroblast proliferation was observed with concentrations of 50 microM ropivacaine or 100 microM lidocaine in 1% newborn calf serum and 500 microM ropivacaine or lidocaine in 10% newborn calf serum. The proliferation of endothelial cells was significantly inhibited by 1 mM ropivacaine in 5% human serum and 500 microM ropivacaine or 100 microM lidocaine in 40% human serum. Significant inhibition was not obtained with lidocaine when these cells were cultured in 5% HS. Significant inhibition of keratinocytes was obtained with 100 microM ropivacaine and 500 microM lidocaine. The effective concentrations are within the range of therapeutical concentrations in vivo and there seems to be a general correlation between the local anaesthetic potency and the inhibiting effect on cell proliferation. This suggest a mechanism by which local anaesthetics may exhibit anti-hyperproliferative effects in clinical situations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8147273     DOI: 10.1007/bf01976755

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  48 in total

1.  Effect of cations and cation channel blockers on human natural killer cells.

Authors:  T Huwyler; A Hirt; D Felix; A Morell
Journal:  Int J Immunopharmacol       Date:  1985

2.  Electroimmunology: the physiologic role of ion channels in the immune system.

Authors:  K G Chandy; T E DeCoursey; M D Cahalan; S Gupta
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

3.  The human vasoactive intestinal peptide receptor: molecular identification by covalent cross-linking in colonic epithelium.

Authors:  A Couvineau; M Laburthe
Journal:  J Clin Endocrinol Metab       Date:  1985-07       Impact factor: 5.958

4.  Electroosmotic interactions accompanying mitosis initation in sarcoma cells in vitro.

Authors:  C D Cone
Journal:  Trans N Y Acad Sci       Date:  1969-04

5.  Structure-activity relationships in differential nerve block at high and low frequency stimulation.

Authors:  J A Wildsmith; D T Brown; D Paul; S Johnson
Journal:  Br J Anaesth       Date:  1989-10       Impact factor: 9.166

6.  Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites.

Authors:  R R MacGregor; R E Thorner; D M Wright
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

7.  Inhibition of mitogen-induced lymphocyte transformation by local anesthetics.

Authors:  R M Ferguson; J R Schmidtke; R L Simmons
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

8.  Inhibition, by anaesthetic agents, of human leucocyte locomotion towards chemical attractants.

Authors:  G C Moudgil; R B Allan; R J Russell; P C Wilkinson
Journal:  Br J Anaesth       Date:  1977-02       Impact factor: 9.166

9.  Effects of insulin, transferrin, cholera toxin, and epidermal growth factor on growth and morphology of human fetal normal colon epithelial cells.

Authors:  D P Chopra; K M Siddiqui; R A Cooney
Journal:  Gastroenterology       Date:  1987-04       Impact factor: 22.682

10.  Serial cultivation of adult human endothelium from the great saphenous vein.

Authors:  A Haegerstrand; C Gillis; L Bengtsson
Journal:  J Vasc Surg       Date:  1992-08       Impact factor: 4.268

View more
  7 in total

1.  Direct inhibition of microtubule-based kinesin motility by local anesthetics.

Authors:  Y Miyamoto; E Muto; T Mashimo; A H Iwane; I Yoshiya; T Yanagida
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

2.  In vitro exposure of human fibroblasts to local anaesthetics impairs cell growth.

Authors:  C Fedder; B Beck-Schimmer; J Aguirre; M Hasler; B Roth-Z'graggen; M Urner; S Kalberer; A Schlicker; G Votta-Velis; J M Bonvini; K Graetz; A Borgeat
Journal:  Clin Exp Immunol       Date:  2010-09-01       Impact factor: 4.330

3.  Effect of Lignocaine Concentration on Human Fibroblasts Growth in Eyes Undergoing Trabeculectomy: An in vitro Study.

Authors:  Madhuravasal Krishnan Janani; Venkatakrishnan Jaichandran; Hajib Narahari Rao Madhavan; Lingam Vijaya; Ronnie Jacob George; Priyam Shrikant Ambastha; Abhijeet Manu; Jambulingam Malathi
Journal:  Biomed Hub       Date:  2018-10-23

4.  Effectiveness of saline water and lidocaine injection treatment of intractable plantar keratoma: a randomised feasibility study.

Authors:  Marie-Philippe Mercier; Virginie Blanchette; Vincent Cantin; Magali Brousseau-Foley
Journal:  J Foot Ankle Res       Date:  2021-04-13       Impact factor: 2.303

5.  Exploring anorectal manometry as a method to study the effect of locally administered ropivacaine in patients with ulcerative colitis.

Authors:  Eva Arlander; Robert Löfberg; Leif Törkvist; Ulrik Lindforss
Journal:  ISRN Gastroenterol       Date:  2013-02-17

6.  Comparison of ropivacaine and fentanyl toxicity in human fibroblasts.

Authors:  Andreas Ficklscherer; Birte Sievers; Julia Redeker; Mehmet F Gülecyüz; Alexander Paulus; Matthias F Pietschmann; Peter E Müller
Journal:  Arch Med Sci       Date:  2013-05-27       Impact factor: 3.318

7.  Deregulation of keratinocyte differentiation and activation: a hallmark of venous ulcers.

Authors:  Olivera Stojadinovic; Irena Pastar; Sasa Vukelic; My G Mahoney; Donna Brennan; Agata Krzyzanowska; Michael Golinko; Harold Brem; Marjana Tomic-Canic
Journal:  J Cell Mol Med       Date:  2008-03-28       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.